Liver Transplantation · 2007 · 10 citations · 18 references
MedicinePharmacologySurgeryHepatic PharmacokineticsTransplant ImmunologyTransplant SurgeryHepatic ClearanceHepatic Function TestingImmunosuppressant MonitoringImmunosuppressionLiver TransplantationPharmacokinetics In Liver DiseaseImmunosuppressant Dose AdjustmentImmunosuppression Level MonitoringIndocyanine Green Dye KineticsIndocyanine Green ImagingPharmacokinetics In Liver TransplantationPharmacokinetics In TransplantationPost-transplant ImmunosuppressionTacrolimus Therapy
Twenty adult patients undergoing orthotopic liver transplantation (OLT) were enrolled in this study, with the noninvasive indocyanine green plasma disappearance rate (ICG-PDR) measured both during and after OLT to assess the relationship between ICG-PDR and the ability of patients to achieve therapeutic postoperative tacrolimus immunosuppressant blood levels. Liver function was determined at both 2 and 18 hours post reperfusion with the ICG-PDR k value (1/min). Postoperative standard serum measures of liver function as well as liver biopsies were also collected and analyzed. The median ICG-PDR k value for the study group at 2 hours post reperfusion was 0.20 (0.16, 0.27), whereas at 18 hours post reperfusion, it was 0.22 (0.18, 0.35). The median change in the k value between the two ICG-PDR measurements was 0.05 (-0.02, 0.07) with P = 0.02. There was an interaction between the postoperative day 1 (18 hours post reperfusion) ICG-PDR k value and the linear increase in the tacrolimus blood level, such that the greater the k value was, the more gradual the observed rise was in tacrolimus over time [that is, the longer it took to achieve a therapeutic blood level (>12 ng/mL), P = 0.003]. Of the 16 patients that received tacrolimus, comparable dosing on a per kilogram body weight basis was observed. Also, no significant association between ICG-PDR k values and postoperative liver biopsy results was seen. This study demonstrates that the ICG-PDR measurement is a modality with the potential to assist in achieving adequate blood levels of tacrolimus following OLT.
18
Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients
Antoine Hadengue, Didier Lebrec, Richard Moreau et al. · Hepatology · 1993 · 148 citations
Medicine, Physiology, Surgery +17
ASSESSMENT OF PRETRANSPLANT PROGNOSIS IN PATIENTS WITH CIRRHOSIS
Michael Oellerich, M. Burdelski, HANS-ULRIC LAUTZ et al. · Transplantation · 1991 · 121 citations